Stephen O'Neil
Recent Quotes
"JNJ's Q2/13 revenue rose 9% from Q2/12 and was $200M above expectations."
—
Stephen O'Neil, Hilliard Lyons
(7/16/13)
more >
"Double-digit growth in pharmaceuticals and medical devices contributed to higher Q1 sales for JNJ."
—
Stephen O'Neil, Hilliard Lyons
(4/17/13)
more >
"We rate JNJ a long term Buy."
—
Stephen O'Neil, Hilliard Lyons
(10/16/12)
more >
"JNJ's first quarter earnings exceeded consensus estimates."
—
Stephen O'Neil, Hilliard Lyons
(4/17/12)
more >
Due to permission requirements, not all quotes are shown.
